PT - JOURNAL ARTICLE AU - Lei Lu AU - Tingting Zhu AU - Antônio H. Ribeiro AU - Lei Clifton AU - Erying Zhao AU - Antonio Luiz P. Ribeiro AU - Yuan-Ting Zhang AU - David A. Clifton TI - Knowledge Discovery with Electrocardiography Using Interpretable Deep Neural Networks AID - 10.1101/2022.11.01.22281722 DP - 2022 Jan 01 TA - medRxiv PG - 2022.11.01.22281722 4099 - http://medrxiv.org/content/early/2022/11/01/2022.11.01.22281722.short 4100 - http://medrxiv.org/content/early/2022/11/01/2022.11.01.22281722.full AB - Despite the potentials of artificial intelligence (AI) in healthcare, very little work focuses on the extraction of clinical information or knowledge discovery from clinical measurements. Here we propose a novel deep learning model to extract characteristics in electrocardiogram (ECG) and explore its usage in knowledge discovery. Utilising a 12-lead ECG dataset (nECGs = 2,322,513) collected from unique subjects (nSubjects = 1,558,772) in primary care, we performed three independent medical tasks with the proposed model: (i) cardiac abnormality diagnosis, (ii) gender identification, and (iii) hypertension screening. We achieved an area under the curve (AUC) score of 0.998 (95% confidence interval (CI), 0.995-0.999), 0.964 (95% CI, 0.963-0.965), and 0.839 (95% CI, 0.837-0.841) for each task, respectively; We provide interpretation of salient morphologies and further identified key ECG leads that achieve similar performance for the three tasks: (i) AVR and V1 leads (AUC=0.990 (95% CI, 0.982-0.995); (ii) V5 lead (AUC=0.900 (95% CI, 0.899-0.902)); and (iii) V1 lead (AUC=0.816 (95% CI, 0.814-0.818)). Using ECGs, our model not only has demonstrated cardiologist-level accuracy in heart diagnosis with interpretability, but also shows its potentials in facilitating clinical knowledge discovery for gender and hypertension detection which are not readily available.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was partially supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. T.Z. was supported by the RAEng Engineering for Development Research Fellowship. A.L.P.R. was supported in part by CNPq (310790/2021-2 and 465518/2014-1) and by FAPEMIG (PPM-00428-17 and RED-00081-16); A.H.R. was partially supported by the Kjell och Marta Beijer Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the Universidade Federal de Minas Gerais (protocol 49368496317.7.0000.5149) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.